Texas 2023 88th Regular

Texas House Bill HB1050 Introduced / Bill

Filed 12/19/2022

Download
.pdf .doc .html
                    88R3072 BEE-D
 By: Hinojosa H.B. No. 1050


 A BILL TO BE ENTITLED
 AN ACT
 relating to the authority of pharmacists to dispense
 self-administered hormonal contraceptives.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter C, Chapter 157, Occupations Code, is
 amended by adding Section 157.102 to read as follows:
 Sec. 157.102.  AUTHORIZATION TO DISPENSE SELF-ADMINISTERED
 HORMONAL CONTRACEPTIVE UNDER WRITTEN PROTOCOL. (a) In this
 section:
 (1)  "Pharmacist" has the meaning assigned by Section
 551.003.
 (2)  "Written protocol" means a physician's written
 order, standing medical order, standing delegation order, or other
 order or protocol as defined by board rule.
 (b)  This section does not apply to:
 (1)  the issuing of a valid patient-specific
 prescription for a hormonal contraceptive by a physician; or
 (2)  the dispensing of a hormonal contraceptive by a
 pharmacist under a prescription described by Subdivision (1).
 (c)  A physician may issue a written protocol to authorize
 the dispensing of a self-administered hormonal contraceptive that
 is approved by the United States Food and Drug Administration to
 prevent pregnancy, including an oral hormonal contraceptive, a
 hormonal contraceptive vaginal ring, or a hormonal contraceptive
 patch.
 (d)  Notwithstanding any other law, in accordance with rules
 adopted under Subsection (e), a pharmacist may dispense a
 self-administered hormonal contraceptive to a patient 18 years of
 age or older under a written protocol and without any other
 patient-specific prescription drug order.
 (e)  In consultation with a national professional
 organization specializing in obstetrics and gynecology, the board
 shall jointly adopt rules with the Texas State Board of Pharmacy to
 establish standard procedures for a pharmacist to dispense a
 self-administered hormonal contraceptive under this section.
 Rules adopted under this subsection must require:
 (1)  a patient to complete and provide to a pharmacist a
 nationally recognized self-screening risk assessment before the
 pharmacist may dispense a self-administered hormonal contraceptive
 to the patient; and
 (2)  a pharmacist to provide the patient with
 information about the contraceptive dispensed to the patient.
 (f)  A physician acting reasonably and in good faith in
 issuing a written protocol for dispensing, or a pharmacist acting
 reasonably and in good faith in dispensing, a self-administered
 hormonal contraceptive under this section is not liable for civil
 damages resulting from an act or omission in the dispensing of the
 contraceptive.
 (g)  A law governing coverage by a health benefit plan of a
 contraceptive drug, device, product, or service applies to a
 self-administered hormonal contraceptive dispensed under this
 section to the same extent that the law applies to a
 self-administered hormonal contraceptive dispensed under a
 patient-specific prescription issued by a physician.
 SECTION 2.  Section 551.003(33), Occupations Code, is
 amended to read as follows:
 (33)  "Practice of pharmacy" means:
 (A)  providing an act or service necessary to
 provide pharmaceutical care;
 (B)  interpreting or evaluating a prescription
 drug order or medication order;
 (C)  participating in drug or device selection as
 authorized by law, and participating in drug administration, drug
 regimen review, or drug or drug-related research;
 (D)  providing patient counseling;
 (E)  being responsible for:
 (i)  dispensing a prescription drug order or
 distributing a medication order;
 (ii)  compounding or labeling a drug or
 device, other than labeling by a manufacturer, repackager, or
 distributor of a nonprescription drug or commercially packaged
 prescription drug or device;
 (iii)  properly and safely storing a drug or
 device; or
 (iv)  maintaining proper records for a drug
 or device;
 (F)  performing for a patient a specific act of
 drug therapy management delegated to a pharmacist by a written
 protocol from a physician licensed in this state in compliance with
 Subtitle B; [or]
 (G)  administering an immunization or vaccination
 under a physician's written protocol; or
 (H)  dispensing a self-administered hormonal
 contraceptive to a patient under a physician's written protocol
 under Section 157.102.
 SECTION 3.  Section 483.001(11), Health and Safety Code, is
 amended to read as follows:
 (11)  "Practice of pharmacy" has the meaning assigned
 by Section 551.003, Occupations Code [means:
 [(A)  provision of those acts or services
 necessary to provide pharmaceutical care;
 [(B)  interpretation and evaluation of
 prescription drug orders or medication orders;
 [(C)  participation in drug and device selection
 as authorized by law, drug administration, drug regimen review, or
 drug or drug-related research;
 [(D)  provision of patient counseling;
 [(E)  responsibility for:
 [(i)  dispensing of prescription drug orders
 or distribution of medication orders in the patient's best
 interest;
 [(ii)  compounding and labeling of drugs and
 devices, except labeling by a manufacturer, repackager, or
 distributor of nonprescription drugs and commercially packaged
 prescription drugs and devices;
 [(iii)  proper and safe storage of drugs and
 devices; or
 [(iv)  maintenance of proper records for
 drugs and devices. In this subdivision, "device" has the meaning
 assigned by Subtitle J, Title 3, Occupations Code; or
 [(F)  performance of a specific act of drug
 therapy management for a patient delegated to a pharmacist by a
 written protocol from a physician licensed by the state under
 Subtitle B, Title 3, Occupations Code].
 SECTION 4.  As soon as practicable after the effective date
 of this Act, the Texas State Board of Pharmacy and the Texas Medical
 Board shall adopt the rules required under Section 157.102,
 Occupations Code, as added by this Act.
 SECTION 5.  This Act takes effect September 1, 2023.